FDA Inspection 999895 — Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. on December 15, 2016 in Jinhua. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 15, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinhua (China)